Effectiveness of the integration of quercetin, turmeric, and N-acetylcysteine in reducing inflammation and pain associated with endometriosis. In-vitro and in-vivo studies.

BACKGROUND: to evaluate the efficacy of oral administration of a novel composition composed of quercetin, curcumin, acetylcysteine in reducing pain in women affected by endometriosis, through the reduction of the inflammatory-hyperproliferative component of the ectopic endometrial tissue. METHODS: Thirty-three women with clinical diagnosis of endometriosis from at least 3 months have been enrolled. Patients have been treated daily with 200 mg of quercetin, 210 mg of dry extract of Curcuma longa (titrated at 95% in curcuminoids) and 150 mg of acetylcysteine (1 tablet of ALLIENDO®) for 2 months. The overall symptomatology with specific reference to dysmenorrhea, pelvic pain and dyspareunia, together with the frequency of nonsteroidal anti-inflammatory drugs (NSAID) drugs assumption have been evaluated at the beginning and at the end of the treatment. RESULTS: Overall, the results collected at the end of the treatment according to the parameters evaluated and above mentioned on the 33 patients enrolled, show a significative improvement in the reduction of pain symptoms associated to endometriosis (P<0.001 for dysmenorrhea, pelvic pain and dyspareunia). The use of NSAIDs together with an overall reduction of their dosage and time of assumption has been reduced as well. No significative side effects have been observed. CONCLUSIONS: The aforementioned results suggest that administration of the composition described can represent a valuable adjuvant treatment in the reduction of pain symptomatology associated to endometriosis, triggered by inflammatory cascade and hyperproliferation of ectopic tissue.

Determinação de paraquate em batatas / Determination of paraquat in potatoes

O Paraquate (1,1'-dimetil-4,4'-bipiridina- dicloreto) é herbicida amplamente utilizado em vários países para diferentes culturas. O objetivo é determinar a concentração de Paraquate em batatas comercializadas em diferentes estabelecimentos da zona leste de São Paulo. Foram coletadas 12 (doze) amostras de batatas adquiridas no comércio varejista (sacolões, ou seja, do de frutas, verduras e legumes; supermercados e feiras livres) da zona leste do município de São Paulo. A quantificação do Paraquate foi baseada na reação de complexação com o ditionito de sódio, gerando composto de cor azulada, cuja absorvância foi lida em espectrofotômetro em comprimento de onda de 600nm. Foi construída a curva padrão e a determinada a equação da reta (y = 1,6448x e R2= 0,9945). O limite de tolerância do herbicida em alimentos é de 0,2 partes por milhão ou 0,2 mg/kg, enquanto que a ingestão diária aceitável (IDA) é de 0,004 mg/kg de peso corpóreo. Assim, pode-se observar que os valores encontrados em três amostras estão acima do limite máximo permitido, enquanto quatro apresentaram concentrações muito próximas ao limite. Os resultados permitem inferir que existe a necessidade de intensificação na fiscalização nos locais de comercialização de alimentos produzidos com a utilização de agrotóxicos.(AU)

Paraquat (1,1'-dimethyl-4,4'- bipyridine-dichloride) is herbicide widely used in several countries in different plantations. The objective is to determine the concentration of Paraquat in potatoes, marketed in different establishments in the eastern zone of São Paulo. Twelve (12) samples of potatoes purchased from the retail trade ("sacolões", ie fruit, vegetable and vegetable markets, supermarkets and free markets) were collected from the eastern part of the city of São Paulo. The quantification of Paraquat was based on the reaction of complexation with the sodium dithionite, generating compound of blue color, whose absorbance was read in a spectrophotometer at wavelength of 600 nm. The standard curve was constructed and the equation of the line was determined (y = 1,6448x e R2 = 0,9945). The tolerance limit of the herbicide in foods is 0.2 parts per million or 0.2 mg/kg, while the acceptable daily intake (ADI) is 0.004 mg/kg body weight. Thus, it can be observed that the values found in three samples are above the maximum allowed limit, while four of them presented concentrations very close to the limit. The results allow inferring that there is a need for intensification in the inspection in the commercial places of food produced with the use of pesticides.

Proteomic fingerprinting of mistletoe (Viscum album L.) via combinatorial peptide ligand libraries and mass spectrometry analysis.

Combinatorial peptide ligand libraries (CPLLs), coupled to mass spectrometry (MS) analysis, have been used to investigate in depth the proteome of Viscum album L. (VA), commonly named European mistletoe, in order to provide a first proteomic fingerprinting. For this purpose, the proteins were captured via CPLLs at two different pH values (acidic and neutral). A total of 648 non-redundant proteins were identified by using two different databases. The two pH values, chosen for bead incubations, have contributed to increment the capture ability: 56% and 31% of CPLLs species were respectively recognized at pH7.2 and at pH2.2. Finally the biological function of identified proteins was evaluated in order to understand their role on human health and the potential benefits of mistletoe extracts in medicine. SIGNIFICANCE: Viscum album L. (VA) extracts are recently used as supporting medicine for cancer therapy, improving patients' survival and increasing their quality of life in medicine. These anticancer effects are investigated and they are probably due to mistletoe's capability to favor tumor cell's death and to modulate the immune system. Although the increasing interest in VA medical benefits, the role of its components in human health remains unclear. In order to exploit this aspect, it is important to comprehensively study proteins present in Viscum album L. (VA) extracts. Nevertheless, since plant proteomics analysis is in most cases handicapped by the presence of high-abundance proteins masking the detection of the low-abundance ones, it is important to overcome this challenge. In this sense, combinatorial peptide ligand libraries (CPLLs) have been used to reduce the dynamic protein concentration range to enable the identification of a higher amount of proteins than employing conventional methods. In this work, a total of 648 non-redundant proteins were identified: 56% and 31% of CPLLs species were respectively recognized at pH7.2 and at pH2.2. This deep proteome identification was useful to investigate the biological functions of proteins in order to evaluate their potential role in human health.

Cytotoxicity evaluation of Curcuma zedoaria (Christm.) Roscoe fluid extract used in oral hygiene products.

OBJECTIVE: This in vitro study evaluated the cytotoxic effects of the Curcuma zedoaria (Christm.) Roscoe (popular name: zedoary) fluid extract, as used in preparations for oral hygiene, mostly for anti-septic purposes. MATERIALS AND METHODS: The cell viability and cell growth were assessed by Trypan blue dye exclusion assay using the LMF cell line derived from oral mucosa. Cell viability (short-term assay) was measured 0, 6, 12 and 24 h after contact with the fluid extract. Cell growth (long-term assay) was analyzed in 1, 3, 5 and 7 days. The experimental groups were those testing the fluid extract obtained from the zedoary rhizome and the extractor liquid (ethanol 70° GL) in the concentrations of 0.01-0.0001% v/v. Fresh DMEM were used in the control cultures. RESULTS: Short-term assay-all studied cultures maintained stable cell viability; Long-term assay-there was progressive cell growth in all studied cultures. CONCLUSION: According to the results, the zedoary fluid extract presents low cytotoxicity and probably can be used in the oral hygiene products.

Análise comparativa de embalagens secundárias e bulas de medicamentos contendo Panax ginseng C. A. Meyer / A comparative analysis of inner wrapping and package inserts for medicines containing Panax ginseng C. A. Meyer

As informações contidas nas bulas e embalagem de medicamentos de diferentes fabricantes contendo Panax ginseng foram analisadas comparativamente com os dados encontrados na literatura científica. Observaram-se bulas longas, com várias informações em relação às indicações de uso, muitas das quais sem comprovação em humanos, e todas foram deficitárias em relação aos .efeitos adversos e interações medicamentosas. Foi observada falta de padronização quanto às posologias, em relação tanto ao extrato seco, quanto ao teor dos ginsenosídeos presentes. Constatou-se a falta de homogeneidade nas informações aos usuários sobre indicações de uso, efeitos adversos e interações medicamentosas entre as oito amostras estudadas.

The information provided on package inserts and inner wrapping of eight products containing Panax ginseng from different manufacturers was compared internally and checked against data from the scientific literature. The inserts included extensive text, containing abundant information on indications for use, but no scientific evidence in humans. All the inserts lacked information on potential adverse effects and drug interaction. There was no standardization as to dose regimens, particularly in relation to the dried extract and ginsenoside concentration. The eight inserts thus showed no concern over standardization, indication for usage, or possible side effects and drug interactions.

[A comparative analysis of inner wrapping and package inserts for medicines containing Panax ginseng C. A. Meyer]. / Análise comparativa de embalagens secundárias e bulas de medicamentos contendo Panax ginseng C. A. Meyer.

The information provided on package inserts and inner wrapping of eight products containing Panax ginseng from different manufacturers was compared internally and checked against data from the scientific literature. The inserts included extensive text, containing abundant information on indications for use, but no scientific evidence in humans. All the inserts lacked information on potential adverse effects and drug interaction. There was no standardization as to dose regimens, particularly in relation to the dried extract and ginsenoside concentration. The eight inserts thus showed no concern over standardization, indication for usage, or possible side effects and drug interactions.

Antimicrobial efficacy of Curcuma zedoaria extract as assessed by linear regression compared with commercial mouthrinses

The antimicrobial activity of Curcuma zedoaria (Christm) Roscoe extract against some oral microorganisms was compared with the antimicrobial activity of five commercial mouthrinses in order to evaluate the potential of the plant extract to be incorporated into formulas for improving or creating antiseptic activity. The in vitro antimicrobial efficacy of plant extracts and commercial products were evaluated against Streptococcus mutans, Enterococcus faecalis, Staphylococcus aureus and Candida albicans using a linear regression method to evaluate the microbial reduction obtained in function of the exposure time, considering as effectiveness a 99.999 percent reduction in count of standardized microbial populations within 60 seconds. The results showed that the antimicrobial efficacy of Curcuma zedoaria (Christm) Roscoe extract was similar to that of commercial products, and its incorporation into a mouthrinse could be an alternative for improving the antimicrobial efficacy of the oral product.

A atividade antimicrobiana do extrato de Curcuma zedoaria (Christm) Roscoe contra algumas bactérias da microbiota bucal foi comparada com a atividade antimicrobiana de cinco anti-sépticos comerciais, a fim de avaliar o potencial do extrato vegetal de ser incorporado em formulações com a finalidade de melhorar ou conferir atividade anti-séptica. A eficácia antimicrobiana in vitro do extrato vegetal e produtos comerciais foi avaliada frente a Streptococcus mutans,Enterococcus faecalis,Staphylococcus aureus e Candida albicans, utilizando o método de regressão linear para avaliar a redução microbiana obtida em função do tempo de exposição, considerando como eficácia a redução de 99,999 por cento na contagem de população microbiana padronizada em 60 segundos. Os resultados demonstraram que a eficácia antimicrobiana do extrato de Curcuma zedoaria (Christm) Roscoe foi similar a de produtos comerciais e que sua incorporação em anti-sépticos bucais pode ser uma alternativa para aumentar a eficácia antimicrobiana de produtos para uso oral.

Análise cromatográfica em camada delgada comparativa de extratos de Curcuma zedoaria (Christm. ) Roscoe / Comparative analysis of Curcuma zedoaria (Christm. ) Roscoe extracts by means of thin-layer chromatography

As várias espécies do gênero Curcuma têm sido estudadas desde a década de 60, pois há muito são amplamente cultivadas e utilizadas na medicina popular de todo sudeste asiático. Hoje seu uso é bem difundido entre nós e, apesar da utilização de várias técnicas para a caracterização dos extratos, o controle de qualidade desses fitoterápicos constitui um desafio para o laboratório de Saúde Pública. Este estudo propõe um método rápido e pouco dispendioso, empregando cromatografia em camada delgada e que mostrou-se eficaz na avaliação de extratos de Curcuma zedoaria

The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically.

PURPOSE: The purpose of this study was to investigate the antitumor activity of SU6668, tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2), fibroblast growth factor receptor 1 (FGFR1), and platelet-derived growth factor receptor beta (PDGFRbeta), as single-agent therapy and in combination with paclitaxel on ovarian carcinoma xenograft models transplanted in the peritoneal cavity of nude mice. EXPERIMENTAL DESIGN: HOC22 and HOC79 ascites-producing human ovarian carcinoma xenografts were transplanted i.p. into nude mice. SU6668 was given p.o. (200 mg/kg, daily) as a single agent or in combination with paclitaxel i.v. (6 mg/kg/dose every other day or 20 mg/kg/dose weekly). Tumor burden was evaluated at the end of the treatment period as ascites volume and tumor cells, VEGF, FGF-2, and PDGF levels in ascites, and involvement of the organ of the peritoneal cavity. Response was evaluated as percentage increment of life span (%ILS). RESULTS: SU6668 affected ascites formation and tumor burden in the peritoneal cavity of nude mice bearing HOC22 and HOC79 xenografts. Decreased levels of VEGF and PDGF in ascites paralleled this effect. The overall survival of the mice bearing HOC xenograft (HOC79 less response than HOC22) was significantly increased by the treatment with SU6668. The magnitude of the effects depended on the length of treatment and tumor burden at the beginning of treatment. The combination of SU6668 with paclitaxel significantly prolonged the survival of mice bearing HOC79, compared with single therapies. SU6668-based combination therapy was more effective with paclitaxel given at the optimal dose and schedule (20 mg/kg every 7 days for 3 doses) than at the same total dose but split (6 mg/kg every 2 days for 10 doses). However, a similar outcome was observed when giving high-dose paclitaxel (20 mg/kg every 7 days for 3 doses) in monotherapy or split low-dose paclitaxel (6 mg/kg every 2 days for 10 doses) but in combination with SU6668. The addition of paclitaxel, by either schedule, to SU6668 treatment inhibited tumor spread in the peritoneal organs (omentum, pancreas, and diaphragm) even at low doses of paclitaxel. A greater effect was observed with prolonged treatments. CONCLUSIONS: This study shows that SU6668 in combination with paclitaxel inhibits ovarian carcinoma progression in the peritoneal cavity, by blocking ascites formation and tumor spread. Because an adequate schedule and dose of the combination might be as effective as conventional chemotherapy, this should be considered as a therapeutic alternative. These findings provide a rationale for the clinical evaluation of combination therapies affecting multiple biological targets in this tumor type.

Importância da reologia em formas farmacêuticas sólidas / Rheology concernment in solid dosage forms

Propriedade de extrema importância no desenvolvimento e otimização de formas farmacêuticas sólidas é a fluidez do sistema. O estudo reológico visa avaliar as propriedades de fluxo pois a facilidade de partículas sólidas em fluirem do alimentador para a matriz de uma máquina de comprimir ou no enchimento de cápsulas, resulta em produto final uniforme com consequente aumento de produção. As propriedades de fluxo são resultantes de muitas forças e as de superfície são as que predominam. Muitos métodos estão disponíveis para medir a extensão das forças interparticulares. Tais medidas são empregadas como índice de fluxo. Os métodos mais utilizados para esta determinação são ângulo de repouso, compressibilidade, velocidade de fluxo e força de cisalhamento. Características inerentes ao sistema (forma, tamanho e distribuição das partículas, sua textura ou rugosidade, energia residual de superfície e área superficial envolvidas) podem influenciar os resultados dos métodos utilizados para avaliação de fluxo, e por esta razão a instrumentação deve estar qualificada e o método devidamente validado

Desenvolvimento de formulaçöes de comprimidos inertes para veicular medicamentos homeopáticos / Development of inert tablet's formulations to incorporate homeopatic medicines

Formulaçöes de comprimidos inertes foram desenvolvidas com a finalidade de se obter formas sólidas para veicular medicamentos homeopáticos. Para tanto, estes devem apresentar comportamento uniforme durante as fases de compressäo e embebiçäo, além de dissolverem-se na boca de forma homogênea e agradável. Foram avaliadas as reologias dos pós e granulados (medidas de ângulo de repouso, densidade aparente e compressibilidade) e as características físicas dos comprimidos (friabilidade, variaçäo de peso médio, dureza e tempo de desintegraçäo). Os comprimidos, de formato lenticular, com 200 mg de peso unitário, foram formulados a partir de lactose (diluente), goma de amido ou xarope simples (aglutinante) e amido em pó (desagregante e lubrificante). Aos granulados foi adicionado estearato de magnésio (lubrificante) e observada a variaçäo de comportamento. A formulaçäo mais adequada continha 90 por cento de lactose, 7,5 por cento de xarope simples, 2,5 por cento de amido em pó e 0,5 por cento de estearato de magnésio.

Influência dos aglutinantes nas características físicas de comprimidos de pó de guaraná (Paullinia cupana H.B.K.). Comparaçäo com amostras adquiridas no comércio / Influence of aglutinant agents in the physical characteristics of guarana powder tablets

Foram desenvolvidas formulaçöes de comprimento de pó de guaraná (Paullinia cupana H.B.K., Sapindaceae), visando facilitar sua administraçäo por via oral, visto que este possui sabor fracamente amargo e adstringente. Foram utilizadas goma de amido, gelatina, sorbitol, xarope simples e goma arábica como aglutinantes, analisando-se em seguida as características físicas dos comprimidos obtidos no comércio. A formulaçäo contendo xarope simples, na concentraçäo de 15,5% apresentou melhor comportameno reológico, capacidade de resistência aos choques e atrito e tempo de desagregaçäo adequado às formulaçöes sólidas de liberaçäo gástrica